✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Product SafetyVaporizersRegulationQuality ControlPatient Safety Why This MattersProduct safety advisories highlight the persistent quality control...
“Hall of Flowers” brings budding cannabis businesses to Ventura – YouTube
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic IndustryProduct QualityRegulationMarket AccessPatient Safety Why This MattersIndustry trade events like Hall of Flowers reflect...
Indiana Will ‘Have To Address’ Marijuana Legalization Because It’s ‘Lagging’ Behind …
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic PolicyMedical AccessInterstate CareClinical InfrastructurePatient Safety Why This Matters Geographic inconsistencies in cannabis policy create...
America Doesn’t Have A ‘Marijuana Problem,’ As NYT Claims—It Has a Cannabis Education …
WHY IT MATTERS: When media and policymakers frame cannabis use as a “problem” rather than an education gap, it slows the development of clinical programs, physician training, and insurance coverage that patients need to access safe, guided care. CLINICAL OVERVIEW: The framing of cannabis as a “marijuana problem” in mainstream media reflects a deeper failure in clinical education, research access, and regulatory coherence rather than an inherent danger of the plant itself. Physicians are not trained in endocannabinoid medicine during medical school, research remains federally restricted, and patients are left navigating a fragmented system without proper clinical guidance.